Paul R. Wratil
-
- Carbohydrate Chemistry and Synthesis 7
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 4
-
- HIV Research and Treatment 2
-
- Glycosylation and Glycoproteins Research 8
-
- COVID-19 epidemiological studies 2
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Virus-based gene therapy research 2
- Co-authors
- Werner ReutterRüdiger HorstkorteOliver T. KepplerLong NguyenAlex MárkiMichael MertensAndreas BennGert Baumann
- Journals
- Journal of Biological Chemistry (2 papers)Angewandte Chemie International Edition (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- GermanyFranceSwitzerland
In The Last Decade
Paul R. Wratil
21 papers receiving 366 citations
Peers
Comparison fields: 5 of 68
- Organic Chemistry 122
- Infectious Diseases 79
- Virology 20
- Molecular Biology 221
- Modeling and Simulation 12
Countries citing papers authored by Paul R. Wratil
This map shows the geographic impact of Paul R. Wratil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Wratil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Wratil more than expected).
Fields of papers citing papers by Paul R. Wratil
This network shows the impact of papers produced by Paul R. Wratil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Wratil. The network helps show where Paul R. Wratil may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul R. Wratil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 22 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 20 | |
| 13 | 2020 | 10 | |
| 14 | 2017 | 4 | |
| 15 | 2017 | 7 | |
| 16 | 2016 | 28 | |
| 17 | 2016 | 6 | |
| 18 | 2015 | 53 | |
| 19 | 2015 | 29 | |
| 20 | 2014 | 18 |
About Paul R. Wratil
Paul R. Wratil is a scholar working on Infectious Diseases, Modeling and Simulation and Virology, having authored 23 papers that have together received 369 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), Glycosylation and Glycoproteins Research (8 papers), Carbohydrate Chemistry and Synthesis (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), COVID-19 Clinical Research Studies (4 papers), Virus-based gene therapy research (2 papers), COVID-19 epidemiological studies (2 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Organic Chemistry (122 citations), Infectious Diseases (79 citations) and Virology (20 citations). Paul R. Wratil has collaborated with scholars based in Germany, France and Switzerland. Frequent co-authors include Werner Reutter, Rüdiger Horstkorte, Oliver T. Keppler, Long Nguyen, Alex Márki, Michael Mertens, Andreas Benn, Gert Baumann, Matthias Klein and Wolfgang M. Kuebler. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.